<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01027936</url>
  </required_header>
  <id_info>
    <org_study_id>NDB-001</org_study_id>
    <nct_id>NCT01027936</nct_id>
  </id_info>
  <brief_title>An Age-Stratified Data Collection Study in Adult Males and Females, Ages 18 and Above to Establish a Normative Database Using the 3D Optical Coherence Tomography 3D OCT-1000 Mark II</brief_title>
  <official_title>An Age-Stratified Data Collection Study in Adult Males and Females, Ages 18 and Above to Establish a Normative Database Using the 3D Optical Coherence Tomography 3D OCT-1000 Mark II</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Topcon Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Topcon Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To collect three dimensional retinal measurements of the optic disc and the macula lutea on
      healthy normal subjects using the 3D OCT-1000 Mark II for the purpose of developing a
      normative database that is stratified by age.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2009</start_date>
  <completion_date type="Anticipated">November 2010</completion_date>
  <primary_completion_date type="Anticipated">March 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>A normative dataset containing a statistical description of expected norms of retinal nerve fiber layer (RNFL) and macula lutea thickness, stratified by age.</measure>
    <time_frame>12 Months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Normal Healthy Volunteers</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        180 male and female volunteers from 6 centers with normal, healthy eyes form six age
        groups, aged 18 years or older.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and Females at least 18 years of age;

          -  Must be a member of one of the 3 ethnic groups: Caucasian, Hispanic or African
             American. Asians, Eastern Indians, and Native Americans have been excluded from this
             study;

          -  Signed, written informed consent obtained for the study;

          -  BSCVA of 20/40 or better in both eyes;

          -  Intraocular pressure (IOP) â‰¤ 21 mm Hg in both eyes.

        Exclusion Criteria:

          -  Ocular disease;

          -  Cataract on slit lamp exam with a corresponding loss of BSCVA worse than 20/25;

          -  Corneal surface disruption precluding imaging;

          -  Prior ocular surgery except uncomplicated phacoemulsification or strabismus surgery;

          -  Prior corneal refractive surgery of any type;

          -  Family history of glaucoma among first generation relatives;

          -  Current history of an acute or chronic disease or illness that would confound the
             normative outcome(s) of the study;

          -  Current use of systemic medications that may confound the outcome of the study;

          -  Nystagmus or any other condition that would prevent a steady gaze during study tests
             or measurements;

          -  Current history of inflammation or infection of the eye or eyelids; injury to the eye.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Weinreb, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>University of California, San Diego; Shiley Eye Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shiley Eye Center UCSD</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Durrie Vision</name>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Glaucoma Associates of New York</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vitreous-Retina-Macula Consultants of New York, P.C.</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10022</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SUNY</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10036</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eye Institute/Medical College of WI</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2009</study_first_submitted>
  <study_first_submitted_qc>December 8, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2009</study_first_posted>
  <last_update_submitted>November 8, 2010</last_update_submitted>
  <last_update_submitted_qc>November 8, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2010</last_update_posted>
  <responsible_party>
    <name_title>Bob Gibson/Senior Director of Marketing and Strategic Planning</name_title>
    <organization>Topcon Medical Systems, Inc.</organization>
  </responsible_party>
  <keyword>Healthy Volunteers</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

